During the last session, Enveric Biosciences Inc (NASDAQ:ENVB)’s traded shares were 0.5 million, with the beta value of the company hitting 0.54. At the end of the trading day, the stock’s price was $1.60, reflecting an intraday gain of 0.63% or $0.01. The 52-week high for the ENVB share is $43.80, that puts it down -2637.5 from that peak though still a striking 8.13% gain since the share price plummeted to a 52-week low of $1.47. The company’s market capitalization is $3.08M, and the average intraday trading volume over the past 10 days was 0.75 million shares, and the average trade volume was 182.06K shares over the past three months.
Enveric Biosciences Inc (NASDAQ:ENVB) trade information
Enveric Biosciences Inc (ENVB) registered a 0.63% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 0.63% in intraday trading to $1.60, hitting a weekly high. The stock’s 5-day price performance is -3.61%, and it has moved by -70.12% in 30 days. Based on these gigs, the overall price performance for the year is -86.91%. The short interest in Enveric Biosciences Inc (NASDAQ:ENVB) is 0.23 million shares and it means that shorts have 1.01 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 71.22%.
ENVB Dividends
Enveric Biosciences Inc is due to release its next quarterly earnings in March. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Enveric Biosciences Inc (NASDAQ:ENVB)’s Major holders
Enveric Biosciences Inc insiders own 0.07% of total outstanding shares while institutional holders control 6.91%, with the float percentage being 6.91%. ADVISORSHARES INVESTMENTS LLC is the largest shareholder of the company, while 18.0 institutions own stock in it. As of 2024-06-30, the company held over 0.32 million shares (or 7.9233% of all shares), a total value of $0.19 million in shares.
The next largest institutional holding, with 44659.0 shares, is of GEODE CAPITAL MANAGEMENT, LLC’s that is approximately 1.1161% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $27688.0.
Also, the Mutual Funds coming in first place with the largest holdings of Enveric Biosciences Inc (ENVB) shares are AdvisorShares Trust-AdvisorShares Psychedelics ETF and Fidelity NASDAQ Composite Index Fund . Data provided on Nov 30, 2024 indicates that AdvisorShares Trust-AdvisorShares Psychedelics ETF owns about 39.99 shares. This amounts to just over 0.39 percent of the company’s overall shares, with a $63984.0 market value. The same data shows that the other fund manager holds slightly less at 10.91, or about 0.11% of the stock, which is worth about $17459.0.
